Skip to content

aptamer selection

Aptamers in prostate cancer in vivo research

Prostate cancer is the most common cancer among men, with approximately 1.1 million new cases diagnosed per year worldwide. Most cancer-related deaths are caused by metastases in vital organs,…

Aptamer Selection

23rd May 2017 AptaBasics: Aptamer Selection At Aptamer Group we can select and identify novel aptamers to specific targets in as little as 12 weeks. To select…